File Download
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Outcomes of unresectable solitary hepatocellular carcinomas sized 5 to 8 CM treated by radiofrequency ablation versus transarterial chemoembolization
Title | Outcomes of unresectable solitary hepatocellular carcinomas sized 5 to 8 CM treated by radiofrequency ablation versus transarterial chemoembolization |
---|---|
Authors | |
Keywords | Medical sciences Gastroenterology |
Issue Date | 2014 |
Publisher | Wiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.wiley.com/WileyCDA/WileyTitle/productCd-HPB.html |
Citation | The 14th Annual Congress of the Americas Hepato-Pancreato-Biliary Association (AHPBA), Miami Beach, FL., 19-23 February 2014. In HPB, 2014, v. 16 suppl. S1, p. 86, abstract MO-A.10 How to Cite? |
Abstract | OBJECTIVE: To compare the efficacy of radiofrequency ablation (RFA) versus transarterial chemoembolization (TACE) in treating large (5–8 cm) unresectable solitary hepatocellular carcinomas (HCCs). DESIGN: Retrospective study of prospectively collected data. SETTING: RFA and TACE as feasible options for treating large solitary HCCs unresectable because of poor liver reserve or other patient factors. PATIENTS AND INTERVENTION: Among 41 patients who had large unresectable solitary HCCs, 15 patients received RFA and 26 patients received TACE. MAIN OUTCOME MEASURES: The primary endpoint was overall survival and the secondary endpoints were tumor response, time to disease progression, and treatment-related morbidity and mortality. RESULTS: The complication rate was 33% in the ... |
Description | This journal suppl. entitled: Special Issue: Abstracts of the Fourteenth Annual Americas Hepato-Pancreato-Biliary Congress ... 2014 Session - Parallel Mini Oral A Liver/Transplant: no. MO-A.10 |
Persistent Identifier | http://hdl.handle.net/10722/198644 |
ISSN | 2023 Impact Factor: 2.7 2023 SCImago Journal Rankings: 1.141 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dai, WC | en_US |
dc.contributor.author | Cheung, TT | en_US |
dc.contributor.author | Poon, R | en_US |
dc.date.accessioned | 2014-07-07T08:29:35Z | - |
dc.date.available | 2014-07-07T08:29:35Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | The 14th Annual Congress of the Americas Hepato-Pancreato-Biliary Association (AHPBA), Miami Beach, FL., 19-23 February 2014. In HPB, 2014, v. 16 suppl. S1, p. 86, abstract MO-A.10 | en_US |
dc.identifier.issn | 1365-182X | - |
dc.identifier.uri | http://hdl.handle.net/10722/198644 | - |
dc.description | This journal suppl. entitled: Special Issue: Abstracts of the Fourteenth Annual Americas Hepato-Pancreato-Biliary Congress ... 2014 | - |
dc.description | Session - Parallel Mini Oral A Liver/Transplant: no. MO-A.10 | - |
dc.description.abstract | OBJECTIVE: To compare the efficacy of radiofrequency ablation (RFA) versus transarterial chemoembolization (TACE) in treating large (5–8 cm) unresectable solitary hepatocellular carcinomas (HCCs). DESIGN: Retrospective study of prospectively collected data. SETTING: RFA and TACE as feasible options for treating large solitary HCCs unresectable because of poor liver reserve or other patient factors. PATIENTS AND INTERVENTION: Among 41 patients who had large unresectable solitary HCCs, 15 patients received RFA and 26 patients received TACE. MAIN OUTCOME MEASURES: The primary endpoint was overall survival and the secondary endpoints were tumor response, time to disease progression, and treatment-related morbidity and mortality. RESULTS: The complication rate was 33% in the ... | - |
dc.language | eng | en_US |
dc.publisher | Wiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.wiley.com/WileyCDA/WileyTitle/productCd-HPB.html | - |
dc.relation.ispartof | HPB | en_US |
dc.rights | The definitive version is available at www3.interscience.wiley.com | - |
dc.subject | Medical sciences | - |
dc.subject | Gastroenterology | - |
dc.title | Outcomes of unresectable solitary hepatocellular carcinomas sized 5 to 8 CM treated by radiofrequency ablation versus transarterial chemoembolization | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Dai, WC: daiwc@hku.hk | en_US |
dc.identifier.email | Cheung, TT: cheung68@hku.hk | en_US |
dc.identifier.email | Poon, R: poontp@hku.hk | en_US |
dc.identifier.authority | Poon, R=rp00446 | en_US |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1111/hpb.12223_17 | - |
dc.identifier.hkuros | 229866 | en_US |
dc.identifier.hkuros | 237483 | - |
dc.identifier.volume | 16 | - |
dc.identifier.issue | suppl. S1 | - |
dc.identifier.spage | 86, abstract MO-A.10 | - |
dc.identifier.epage | 86, abstract MO-A.10 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1365-182X | - |